Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma

University of Kansas Medical Center1 site in 1 country50 target enrollmentJuly 17, 2020

ConditionsRenal Cell Carcinoma

Overview

Phase: N/A
Intervention: Not specified
Conditions: Renal Cell Carcinoma
Sponsor: University of Kansas Medical Center
Enrollment: 50
Locations: 1
Primary Endpoint: Utility of Renal Ultrasonography (US) in the detection of abdominal recurrences
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detection rate to that of cross-sectional imaging.

Registry

clinicaltrials.gov

Start Date

July 17, 2020

End Date

December 1, 2022

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

University of Kansas Medical Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients must be 18 year of age or older.
•Patients having undergone radical or partial nephrectomy for the indication of renal cell carcinoma.
•Most recent imaging study must have been either computed tomography (CT) or magnetic resonance imaging (MRI).

Exclusion Criteria

•Patients with pT4 disease (tumor invades beyond the Gerota fascia: including contiguous extension into the ipsilateral adrenal gland).
•Patients with metastatic disease prior to time of surgery requiring systemic treatment.
•Patients with another active cancer diagnosis requiring systemic treatment.
•Patients with contrast allergies.
•Patients with baseline chronic kidney disease (GFR \< 45 ml/min/1.73 m2).

Outcomes

Primary Outcomes

Utility of Renal Ultrasonography (US) in the detection of abdominal recurrences

Time Frame: 4 weeks

Renal Cell Carcinoma (RCC) recurrence detection of ultrasonography in patients who have undergo definitive therapy for RCC compared to detection rate of cross-sectional imaging